Search results
uniQure (QURE) Partner Gets FDA Nod for Hemophilia B Gene Therapy
Zacks via Yahoo Finance· 1 year agoShares of uniQure QURE were up 7.08% during market hours after the company announced that its...
The most expensive drug in the world has a $3.5 million price tag. 2 potential patients share their...
Business Insider via Yahoo News· 1 year agoBryen Lackey, 18, has the genetic bleeding disorder hemophilia B. He said he could be interested in...
A hemophilia drug that just won FDA approval pegs a one-time $3.5 million vial against several...
Quartz via Yahoo Finance· 1 year agoThere’s a new one-time treatment for Hemophilia B patients in the market, but it comes with an...
Pfizer Wins FDA Approval For $3.5 Million Gene Therapy, Rivaling CSL, Uniqure
Investor's Business Daily· 3 days agoThe Food and Drug Administration approved Pfizer's hemophilia B gene therapy on Friday, a one-time...
uniQure (QURE) Up on Restructuring Plans, Workforce Reduction
Zacks via Yahoo Finance· 7 months agoShares of uniQure N.V. QURE were up 11.61% on Oct 5 after the company announced a strategic...
$3.5M gene therapy for hemophilia gets FDA approval
Associated Press via Yahoo News· 1 year agoU.S. health regulators on Tuesday approved the first gene therapy for hemophilia, a $3.5 million one-time treatment for the blood-clotting disorder. The...
Biotech Stock Roundup: BMY Grabs MRTX, AKRO Down on Study Data, ALNY Faces Setback
Zacks via Yahoo Finance· 7 months agoIt was a busy week for the biotech sector. M&A is back in the spotlight in the sector as Bristol...
Regulators have approved the world's most expensive medicine that costs $3.5 million per patient
Business Insider via Yahoo News· 1 year agoHemgenix can be used to treat adults with hemophilia.Ivan Balvan/Getty Images The FDA approved a...
Why Shares of uniQure Are Up Thursday
Motley Fool· 7 months agoShares of uniQure (NASDAQ: QURE) were up more than 8% as of 1 p.m. after rising as much as 14% earlier in the day. The biggest move is that uniQure said...
Australia's CSL prices hemophilia gene therapy at $3.5 million
Reuters via Yahoo News· 1 year ago(Reuters) -Australian drugmaker CSL Ltd on Tuesday set the list price of its one-time gene therapy...
